Energy coupling in lysolecithin-treated submitochondrial particles.
D000251:Adenosine Triphosphatases / Q000378:metabolism; D000818:Animals; D001562:Benzimidazoles / Q000494:pharmacology; D001693:Biological Transport, Active; D002258:Carbonyl Cyanide m-Chlorophenyl Hydrazone / Q000494:pharmacology; D002259:Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone / Q000494:pharmacology; D002417:Cattle; D004579:Electron Transport; D006863:Hydrogen-Ion Concentration; D008244:Lysophosphatidylcholines / Q000494:pharmacology*; D008854:Microscopy, Electron; D008931:Mitochondria, Muscle / Q000187:drug effects / Q000378:metabolism* / Q000648:ultrastructure; D009206:Myocardium; D009550:Nigericin / Q000494:pharmacology; D011188:Potassium / Q000378:metabolism; D014634:Valinomycin / Q000494:pharmacology
D001562:Benzimidazoles; D008244:Lysophosphatidylcholines; D014634:Valinomycin; D002259:Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone; D002258:Carbonyl Cyanide m-Chlorophenyl Hydrazone; D000251:Adenosine Triphosphatases; D009550:Nigericin; D011188:Potassium